We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
-18.83%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$82.2M
AUM Growth
-$32M
Cap. Flow
-$8.33M
Cap. Flow %
-10.13%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
RCKT icon
Rocket Pharmaceuticals
RCKT
+$746K
2
ITRM
Iterum Therapeutics
ITRM
+$3

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$9.08M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$569M
$34.3M 41.74%
1,289,521
– –
EWTX icon
2
Edgewise Therapeutics
EWTX
$4.65B
$28M 34.03%
1,553,661
– –
CRNX icon
3
Crinetics Pharmaceuticals
CRNX
$8.9B
$6.32M 7.68%
141,000
– –
RLYB icon
4
Rallybio
RLYB
$85M
$4.42M 5.38%
412,700
– –
RCKT icon
5
Rocket Pharmaceuticals
RCKT
$387M
$3.24M 3.95%
150,706
+32,464
+27% +$746K
COGT icon
6
Cogent Biosciences
COGT
$7.22B
$2.11M 2.57%
250,765
– –
PASG icon
7
Passage Bio
PASG
$14.2M
$1.98M 2.41%
124,896
– –
ALEC icon
8
Alector
ALEC
$204M
$1.54M 1.87%
339,569
– –
XFOR icon
9
X4 Pharmaceuticals
XFOR
$425M
$194K 0.24%
11,167
– –
ITRM
10
DELISTED
Iterum Therapeutics
ITRM
$111K 0.14%
97,086
+2
+0% +$3
DCPH
11
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-576,975
Closed -$9.08M

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q2 2024 Portfolio in Review

As of Q2 2024, New Leaf Venture Partners held 11 positions worth $82.2M, down 28% from $114M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

New Leaf Venture Partners withdrew a net $8.33M in Q2 2024, closing 1 position. Its most notable exit was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $9.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, New Leaf Venture Partners added an estimated $746K to Rocket Pharmaceuticals.

  • New Leaf Venture Partners added most to Rocket Pharmaceuticals in Q2 2024, an estimated $746K increase.
  • New Leaf Venture Partners fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $9.08M.
  • New Leaf Venture Partners's ten largest holdings make up 100% of its $82.2M portfolio in Q2 2024.
  • New Leaf Venture Partners opened 0 new positions and closed 1 in Q2 2024.
  • New Leaf Venture Partners's portfolio value fell 28% quarter-over-quarter to $82.2M.

Based on New Leaf Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.